RRML - Platelet function monitoring tests in the evaluation of platelet antagonists efficacy
AMLR

ISSN online: 2284-5623

ISSN-L: 1841-6624

Impact factor (2016): 0.325

Rejection rate (2016): 55%

Română English


SCImago Journal & Country Rank


Advanced search


Top 10 downloaded articles
- October 2017 -
 
Effect of long period treatment w... 6
Screening for common cystic fibro... 5
IL-6 gene polymorphisms and sepsi... 5
Association of ischemia-modified ... 5
Association of methionine synthas... 4
Epigenetic changes in myelodyspla... 4
Romanian Review of Laboratory Med... 4
Therapy-related myelodysplastic s... 4
Involvement of inflammatory marke... 4
Effects of low-molecular weight a... 4

Log in

Concept, Design & Programming
Dr. Adrian Man

   
 
Nr. 13(4)/2008
XML
TXT

Platelet function monitoring tests in the evaluation of platelet antagonists efficacy

Teste de monitorizare a funcţiei plachetare în evaluarea eficacităţii antagoniştilor plachetari

Elena Bobescu


Abstract

The development of pharmacologic agents that inhibit platelet function leads to the similar development of laboratory methods for evaluation of therapeutic efficacy, low response or drug resistance and monitoring of complications represented by minor or major bleeding. Specific and non-specific platelet antagonists act by inhibiting one or several platelet functions. Platelet antagonists are in relation with function inhibition agents that inhibit platelet adhesion, activation, aggregation and secretion. Platelet functions monitoring has many applications during surgery, in haematology, in cardiovascular disease and research applications. High spontaneous aggregability, low response or resistance to anti-platelet drugs are risk factors for thromboembolic events. In these conditions many methods were developed for evaluation of platelet and platelet function starting with simple tests like blood smear, platelet count, mean platelet volume, in vivo bleeding time, in vitro bleeding time to more specific and standardised methods such as: Rapid Platelet Function Assay, determination of eicosanoids specific platelets metabolites, flow-cytometric determination of vasodilator-stimulated phosphoprotein phosphorylation, light transmission platelet aggregometry, impedance aggregometry - multiple electrode platelet aggregometry. The last method - impedance aggregometry seems to be the best suited for the clinical monitoring of anti-platelet therapy because it analyzes the platelet function in whole blood, similarly to the in vivo conditions, it is sensitive for all the three classes of commonly used platelet function inhibitors, provides a wide range of aggregation tests, it is standardised and cost effective in comparison with previously used methods.

Keywords: platelet function monitoring,platelet antagonists,drug resistance

 
  PDF Download full text PDF
(198 KB)
     
 
How to cite
Bobescu E. Platelet function monitoring tests in the evaluation of platelet antagonists efficacy. Rev Romana Med Lab. 2008;13(4):7-16